
BELLUS Health BLU
Annual report 2022
added 12-28-2024
BELLUS Health ROE Ratio 2011-2026 | BLU
Annual ROE Ratio BELLUS Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -21.59 | -29.73 | - | -7.13 | -26.13 | 1.95 | -20.31 | -8.06 | -119.67 | -8.82 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.95 | -119.67 | -26.61 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
ADC Therapeutics SA
ADCT
|
-138.5 | $ 3.78 | - | $ 105 M | ||
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
Akebia Therapeutics
AKBA
|
-16.39 | $ 1.35 | -2.17 % | $ 347 M | ||
|
Akari Therapeutics, Plc
AKTX
|
-61.06 | $ 3.5 | -21.7 % | $ 236 B | ||
|
Aldeyra Therapeutics
ALDX
|
-76.49 | $ 1.58 | -4.82 % | $ 94.9 M | ||
|
Aligos Therapeutics
ALGS
|
-45.18 | $ 8.36 | 4.89 % | $ 82.6 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
39.76 | $ 330.71 | 3.72 % | $ 43.3 B | ||
|
Altimmune
ALT
|
-39.17 | $ 3.47 | 3.89 % | $ 306 M | ||
|
ALX Oncology Holdings
ALXO
|
-391.42 | $ 1.98 | 0.25 % | $ 106 M | ||
|
Amgen
AMGN
|
89.06 | $ 346.45 | -0.43 % | $ 186 B | ||
|
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | ||
|
Amneal Pharmaceuticals
AMRX
|
-101.78 | $ 12.37 | -0.92 % | $ 3.88 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
Anika Therapeutics
ANIK
|
-38.95 | $ 15.0 | 1.32 % | $ 220 M | ||
|
ANI Pharmaceuticals
ANIP
|
-4.59 | $ 76.34 | 2.87 % | $ 1.47 B | ||
|
Annexon
ANNX
|
-97.66 | $ 5.64 | 2.45 % | $ 875 M | ||
|
Aptorum Group Limited
APM
|
-20.19 | $ 0.92 | -1.11 % | $ 5.02 M | ||
|
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Aprea Therapeutics
APRE
|
-101.27 | $ 0.73 | 2.63 % | $ 4.77 M | ||
|
Aquestive Therapeutics
AQST
|
248.9 | $ 4.15 | 0.48 % | $ 444 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-30.74 | $ 8.43 | 4.98 % | $ 231 M | ||
|
Ardelyx
ARDX
|
-36.9 | $ 6.08 | 2.27 % | $ 1.47 B | ||
|
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | ||
|
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 23.93 | 1.27 % | $ 3.04 B | ||
|
Arvinas
ARVN
|
-18.62 | $ 11.11 | 2.4 % | $ 788 M | ||
|
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
-0.35 | $ 61.57 | 0.88 % | $ 8.24 B | ||
|
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
Assembly Biosciences
ASMB
|
-2.96 | $ 30.01 | 3.43 % | $ 336 M | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | ||
|
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
Actinium Pharmaceuticals
ATNM
|
-432.56 | $ 1.14 | 16.28 % | $ 35.6 M | ||
|
Atossa Therapeutics
ATOS
|
-88.35 | $ 5.21 | -2.89 % | $ 44.9 M | ||
|
Atara Biotherapeutics
ATRA
|
-84.9 | $ 5.03 | 0.7 % | $ 63.1 M | ||
|
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | ||
|
Aurinia Pharmaceuticals
AUPH
|
36.26 | $ 16.04 | 2.75 % | $ 2.16 B | ||
|
Autolus Therapeutics plc
AUTL
|
-161.42 | $ 1.42 | 0.35 % | $ 378 M | ||
|
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
-294.78 | - | 10.36 % | $ 9.8 M |